Menu
Home
Forums
Forums
Quick Links
Search Forums
Recent Posts
job listings
catering
whistleblower info
legal help
advertise on CP
submit press release
Menu
Log in
Sign up
Search titles only
Posted by Member:
Separate names with a comma.
Newer Than:
Search this thread only
Search this forum only
Display results as threads
More...
Useful Searches
Recent Posts
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Valeant Pharmaceuticals
>
Valeant Keeps full year earnings guidance unchanged
>
Reply to Thread
Name:
Verification:
Answer the above question:
(
CustomImgCaptcha
By
Surrey Forum
)
Message:
<p>[QUOTE="RobertPhillips900, post: 5955438, member: 30268"]<a href="http://alph.st/b07a566e" target="_blank" class="externalLink ProxyLink" data-proxy-href="http://alph.st/b07a566e" rel="nofollow">Valeant posted a quarterly profit</a> helped by the strong performance of its Bausch and Lomb Business. </p><p>Net income attributable to Valeant rose to $1.30Bil, or $3.69 per share, during the quarter , compared with a loss of $1.22Bil, or $3.49 per share, a year earlier.</p><p><br /></p><p>Total revenue fell 10.5% to $2.22Bil, reflecting volume declines in its US diversified products and branded businesses.</p><p><br /></p><p>Take a look at the earnings highlights including the guidance <a href="http://alph.st/b07a566e" target="_blank" class="externalLink ProxyLink" data-proxy-href="http://alph.st/b07a566e" rel="nofollow">http://alph.st/b07a566e</a>[/QUOTE]</p><p><br /></p>
[QUOTE="RobertPhillips900, post: 5955438, member: 30268"][URL='http://alph.st/b07a566e']Valeant posted a quarterly profit[/URL] helped by the strong performance of its Bausch and Lomb Business. Net income attributable to Valeant rose to $1.30Bil, or $3.69 per share, during the quarter , compared with a loss of $1.22Bil, or $3.49 per share, a year earlier. Total revenue fell 10.5% to $2.22Bil, reflecting volume declines in its US diversified products and branded businesses. Take a look at the earnings highlights including the guidance [URL]http://alph.st/b07a566e[/URL][/QUOTE]
Your name or email address:
Do you already have an account?
No, create an account now.
Yes, my password is:
Forgot your password?
Stay logged in
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Valeant Pharmaceuticals
>
Valeant Keeps full year earnings guidance unchanged
>
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Valeant Pharmaceuticals
>
Valeant Keeps full year earnings guidance unchanged
>